Temporal trends in the presentation of cardiovascular and cerebrovascular emergencies during the COVID-19 pandemic in Germany: an analysis of health insurance claims

• DOI: 10.1007/s00392-020-01723-9
• Publication Date: 2020-08-04T15:04:53Z
• Authors: Moritz Seiffert; Fabian J. Brunner; Marko Remmel; Götz Thomalla; Ursula Marschall; Helmut L’Hoest; Laura Acar; Eike S. Debus; Stefan Blankenberg; Christian Gerloff; Christian-Alexand...
• Keywords: Male; Time Factors; Databases, Factual; Comorbidity; Health Services Accessibility; 03 medical and health sciences; Patient Admission; 0302 clinical medicine; Germany; Humans; Aged; Retrospective Studies; Original Paper; COVID-19; General Medicine; Patient Acceptance of Health Care; 3. Good health; Cerebrovascular Disorders; Cardiovascular Diseases; Female; Cardiology Service, Hospital; Cardiology and Cardiovascular Medicine; Emergency Service, Hospital; Administrative Claims, Healthcare

Abstract Aims The first reports of declining hospital admissions for major cardiovascular emergencies during the COVID-19 pandemic attracted public attention. However, systematic evidence on this subject is sparse. We aimed to investigate the rate of emergent hospital admissions, subsequent invasive treatments and comorbidities during the COVID-19 pandemic in Germany.

Methods and results This was a retrospective analysis of health insurance claims data from the second largest insurance fund in Germany, BARMER. Patients hospitalized for acute myocardial infarction, acute limb ischemia, aortic rupture, stroke or transient ischemic attack (TIA) between January 1, 2019, and May 31, 2020, were included. Admission rates per 100,000 insured, invasive treatments and comorbidities were compared from January–May 2019 (pre-COVID) to January–May 2020 (COVID). A total of 115,720 hospitalizations were included in the current analysis (51.3% females, mean age 72.9 years). Monthly admission rates declined from 78.6/100,000 insured (pre-COVID) to 70.6/100,000 (COVID). The lowest admission rate was observed in April 2020 (61.6/100,000). Administration rates for ST-segment elevation myocardial infarction (7.3–6.6), non-ST-segment elevation myocardial infarction (16.8–14.6), acute limb ischemia (5.1–4.6), stroke (35.0–32.5) and TIA (13.7–11.9) decreased from pre-COVID to COVID. Baseline comorbidities and the percentage of these patients treated with interventional or open-surgical procedures remained similar over time across all entities. In-hospital mortality in hospitalizations for stroke increased from pre-COVID to COVID (8.5–9.8%).

Conclusions Admission rates for cardiovascular and cerebrovascular emergencies declined during the pandemic in Germany, while patients’ comorbidities and treatment allocations remained unchanged. Further investigation is warranted to identify underlying reasons and potential implications on patients’ outcomes.

Graphic abstract